TREE NEWS update: Eli Lilly said its drug Foundayo is associated with a reduction in long-term predicted risk of type 2 diabetes and cardiovascular disease. The finding links the treatment to lower modeled risk scores for the two conditions over the long term. No further figures or trial details were disclosed.
Eli Lilly: Foundayo Linked to Lower Long-Term Predicted Risk of Type 2 Diabetes and Cardiovascular Disease
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
15m ago
Fed Overnight Reverse Repo Usage Rises to $351M
15m ago
US CENTCOM Commander Visits Israel for Talks with IDF Chief of Staff
36m ago
LME copper falls $30 to $13,226/ton; nickel gains $604
37m ago
Russian President Putin Arrives in Shenzhen
46m ago
Houthis claim drone strike on Saudi east-west oil pipeline
57m ago
Russia Says It Downed 51 Ukrainian Drones Over Multiple Regions in Past Day